e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Lung neoplasms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can VEGF be used in differential diagnosis of pleural effusions?
A. Kanbay, S. Demirtas, I. K. Oguzulgen, O. Kokturk, O. Gulbahar, N. Bukan (Ankara, Turkey)
Source:
Annual Congress 2007 - Lung neoplasms
Session:
Lung neoplasms
Session type:
Thematic Poster Session
Number:
3366
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kanbay, S. Demirtas, I. K. Oguzulgen, O. Kokturk, O. Gulbahar, N. Bukan (Ankara, Turkey). Can VEGF be used in differential diagnosis of pleural effusions?. Eur Respir J 2007; 30: Suppl. 51, 3366
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Pleural fluid leptin level for the differential diagnosis of pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006
Is pleural VEGF a useful parameter?
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007
Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid
Source: Eur Respir J 2006; 28: Suppl. 50, 455s
Year: 2006
Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006
Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012
The value of adenosin-deaminase in etiologic diagnosis of pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 167s
Year: 2002
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Is ²blind² pleural biopsy still of value in tuberculous effusions?
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008
Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
Pleural fluid interleukin-10 level in the diagnosis of tuberculous effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 581s
Year: 2002
The Role of PET-CT in differential diagnosis of malignant-paramalignant pleural effusion
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018
Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Diagnostic value of IL-8 in differentiating between exudative and transudative pleural effusion
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
The diagnostic usefulness of MAGE expression in the diagnosis of exudative pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 528s
Year: 2004
Malignant pleural effusions: diagnosis and management
Source: International Congress 2017 – PG5 Pleural disease management
Year: 2017
The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions
Source: Annual Congress 2009 - Pleural diseases
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept